These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 39407276)

  • 1. Sustainability of opioid agonist therapy programmes in Belarus, the Republic of Moldova, Tajikistan and Ukraine in the context of transition from Global Fund support during 2020-2023.
    Stuikyte R; Varentsov I; Malikov N; Dvoriak S; Filippovych M; Latypov A; Kralko A; Iatco A; Cook C
    Harm Reduct J; 2024 Oct; 21(1):183. PubMed ID: 39407276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measuring sustainability of opioid agonist therapy programs in the context of transition from global fund support.
    Stuikyte R; Varentsov I; Cook C; Dvoriak S
    Harm Reduct J; 2024 Jan; 21(1):7. PubMed ID: 38212809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness of expanding the capacity of opioid agonist treatment in Ukraine: dynamic modeling analysis.
    Morozova O; Crawford FW; Cohen T; Paltiel AD; Altice FL
    Addiction; 2020 Mar; 115(3):437-450. PubMed ID: 31478285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perspectives of clients and providers on factors influencing opioid agonist treatment uptake among HIV-positive people who use drugs in Indonesia, Ukraine, and Vietnam: HPTN 074 study.
    Kiriazova T; Go VF; Hershow RB; Hamilton EL; Sarasvita R; Bui Q; Lancaster KE; Dumchev K; Hoffman IF; Miller WC; Latkin CA
    Harm Reduct J; 2020 Oct; 17(1):69. PubMed ID: 32998731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The real-world impact of dosing of methadone and buprenorphine in retention on opioid agonist therapies in Ukraine.
    Farnum SO; Makarenko I; Madden L; Mazhnaya A; Marcus R; Prokhorova T; Bojko MJ; Rozanova J; Dvoriak S; Islam Z; Altice FL
    Addiction; 2021 Jan; 116(1):83-93. PubMed ID: 32428276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary healthcare-based integrated care with opioid agonist treatment: First experience from Ukraine.
    Morozova O; Dvoriak S; Pykalo I; Altice FL
    Drug Alcohol Depend; 2017 Apr; 173():132-138. PubMed ID: 28242537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of expanding opioid agonist therapies on the HIV epidemic and mortality in Ukraine: a modelling study.
    Tan J; Altice FL; Madden LM; Zelenev A
    Lancet HIV; 2020 Feb; 7(2):e121-e128. PubMed ID: 31879250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The 2023 Latin America report of the
    Hartinger SM; Palmeiro-Silva YK; Llerena-Cayo C; Blanco-Villafuerte L; Escobar LE; Diaz A; Sarmiento JH; Lescano AG; Melo O; Rojas-Rueda D; Takahashi B; Callaghan M; Chesini F; Dasgupta S; Posse CG; Gouveia N; Martins de Carvalho A; Miranda-Chacón Z; Mohajeri N; Pantoja C; Robinson EJZ; Salas MF; Santiago R; Sauma E; Santos-Vega M; Scamman D; Sergeeva M; Souza de Camargo T; Sorensen C; Umaña JD; Yglesias-González M; Walawender M; Buss D; Romanello M
    Lancet Reg Health Am; 2024 May; 33():100746. PubMed ID: 38800647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of emergency guidance to the COVID-19 pandemic on treatment entry, retention and mortality among patients on methadone in Ukraine.
    Ivasiy R; Madden LM; Meteliuk A; Machavariani E; Ahmad B; Zelenev A; Desai MM; Bromberg DJ; Polonsky M; Galvez de Leon SJ; Farnum SO; Islam Z; Altice FL
    Addiction; 2024 Sep; 119(9):1585-1596. PubMed ID: 38807448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Using nominal group technique among clinical providers to identify barriers and prioritize solutions to scaling up opioid agonist therapies in Ukraine.
    Madden L; Bojko MJ; Farnum S; Mazhnaya A; Fomenko T; Marcus R; Barry D; Ivanchuk I; Kolomiets V; Filippovych S; Dvoryak S; Altice FL
    Int J Drug Policy; 2017 Nov; 49():48-53. PubMed ID: 28957756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of the 2014 military conflict in the east of Ukraine and the Autonomous Republic of the Crimea among patients receiving opioid agonist therapies.
    Meteliuk A; Sazonova Y; Goldmann E; Xu S; Liutyi V; Liakh T; Spirina T; Lekholetova M; Islam Z; Ompad DC
    J Subst Use Addict Treat; 2024 May; 160():209312. PubMed ID: 38336264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors associated with physical and sexual violence by police among people who inject drugs in Ukraine: implications for retention on opioid agonist therapy.
    Kutsa O; Marcus R; Bojko MJ; Zelenev A; Mazhnaya A; Dvoriak S; Filippovych S; Altice FL
    J Int AIDS Soc; 2016; 19(4 Suppl 3):20897. PubMed ID: 27435717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Responding to health policy recommendations on managing opioid use disorder during Russia's invasion of Ukraine: Divergent responses from the frontline to the west.
    Ivasiy R; Galvez de Leon SJ; Meteliuk A; Fomenko T; Pykalo I; Bromberg DJ; Madden LM; Farnum SO; Islam Z; Altice FL
    Front Public Health; 2022; 10():1044677. PubMed ID: 36711398
    [No Abstract]   [Full Text] [Related]  

  • 14. The Future of Opioid Agonist Therapies in Ukraine: A Qualitative Assessment of Multilevel Barriers and Ways Forward to Promote Retention in Treatment.
    Bojko MJ; Mazhnaya A; Marcus R; Makarenko I; Islam Z; Filippovych S; Dvoriak S; Altice FL
    J Subst Abuse Treat; 2016 Jul; 66():37-47. PubMed ID: 27211995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Re-examining provider perceptions of best pre-war practices: what elements can help opiate agonist therapy programs in Ukraine successfully survive the crisis?
    Dellamura P; Meteliuk A; Fomenko T; Rozanova J
    Front Public Health; 2023; 11():1259488. PubMed ID: 38239802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of HIV-1 drug resistance in Eastern European and Central Asian countries.
    Kirichenko A; Kireev D; Lopatukhin A; Murzakova A; Lapovok I; Saleeva D; Ladnaya N; Gadirova A; Ibrahimova S; Safarova A; Grigoryan T; Petrosyan A; Sarhatyan T; Gasich E; Bunas A; Glinskaya I; Yurovsky P; Nurov R; Soliev A; Ismatova L; Musabaev E; Kazakova E; Rakhimova V; Pokrovsky V
    PLoS One; 2022; 17(1):e0257731. PubMed ID: 35061671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retention in medication-assisted treatment programs in Ukraine-Identifying factors contributing to a continuing HIV epidemic.
    Dumchev K; Dvoryak S; Chernova O; Morozova O; Altice FL
    Int J Drug Policy; 2017 Oct; 48():44-53. PubMed ID: 28800420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concurrent drug injection during opioid agonist treatment among people who inject drugs in Ukraine.
    Makarenko I; Mazhnaya A; Marcus R; Pykalo I; Madden L; Filippovich S; Dvoriak S; Altice FL
    J Subst Abuse Treat; 2018 Apr; 87():1-8. PubMed ID: 29471921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progress Update: Development of Palliative Care From 2017 to 2020 in Five Countries in Eurasia.
    Lohman D; Abidjanova N; Amiryan D; Gherman L; Kiknadze N; Mayilyan Z; Papikyan A; Pardy S; Shapoval K; Slobozian V; Turcanu G; Tymoshevska V; Zopunyan V
    J Pain Symptom Manage; 2022 Aug; 64(2):100-109. PubMed ID: 35489664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patterns and trends in human papillomavirus-related diseases in Central and Eastern Europe and Central Asia.
    Bray F; Lortet-Tieulent J; Znaor A; Brotons M; Poljak M; Arbyn M
    Vaccine; 2013 Dec; 31 Suppl 7():H32-45. PubMed ID: 24332296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.